PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Nov-2022 Sphingolipids Market will reach a value of US$ 991.8 Mn by 2032 at a CAGR of 5.1% , Says FMI MARKITWIRED
04-Nov-2022 Surface Plasmon Resonance Market Growth Predictions: USD 1807.7 million by 2032 | Future Market Insights MARKITWIRED
04-Nov-2022 Which Are The Main Driving Factors affecting The Nurse Call System Market? Wired Release
04-Nov-2022 The Rising Burden Of Infectious Diseases Has Affected Growth Of The Infectious Disease Diagnostics Market Wired Release
04-Nov-2022 Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions Creative Proteomics
04-Nov-2022 Creative Proteomics Boosts Your Project with Unknown Metabolite Identification Services Creative Proteomics
04-Nov-2022 Creative Proteomics Cytokine Announces the Launch of Chemokine Detection Service Creative Proteomics
04-Nov-2022 Kinarus Therapeutics Provides Strategic Update Kinarus Therapeutics Holding AG
04-Nov-2022 Cimeio Therapeutics Announces Acceptance of ASH Abstracts Detailing Pipeline Businesswire
03-Nov-2022 Puma Biotechnology Reports Third Quarter 2022 Financial Results Businesswire
03-Nov-2022 Verastem Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress Businesswire
03-Nov-2022 Prothena Reports Third Quarter 2022 Financial Results and Business Highlights Businesswire
03-Nov-2022 Legend Biotech Shares Updated Data from Comprehensive Cilta-Cel Clinical Development Program at ASH 2022 Businesswire
03-Nov-2022 Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results Businesswire
03-Nov-2022 Origin Materials, Inc. Reports Financial Results for Third Quarter 2022 Businesswire
03-Nov-2022 Rocket Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Progress Businesswire
03-Nov-2022 MedinCell’s Partner Teva Today Announced Refiling for Approval of mdc-IRM and Confirmed Planned Launch in the U.S. in H1 2023 Businesswire
03-Nov-2022 MedinCell’s Partner Teva Today Announced Refiling for Approval of mdc-IRM and Confirmed Planned Launch in the U.S. in H1 2023 Businesswire
03-Nov-2022 Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year” Businesswire
03-Nov-2022 New Report Shows Life Sciences as a Major Economic and Innovation Engine for Georgia Businesswire